Utility of the fibrinogen/C-reactive protein ratio for the diagnosis of disseminated intravascular coagulation

Acta Haematologica

Volumn 117, Issue 1, 2006, Pages 34-39

  Kim, Hyun Kyung ^a   Lee, Dong Soon ^a   Kang, Seong Ho ^a   Kim, Jin Q ^a   Park, Seonyang ^a   Cho, Han Ik ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

C reactive protein; Disseminated intravascular coagulation; Fibrinogen

Indexed keywords

C REACTIVE PROTEIN; FIBRIN; FIBRINOGEN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AREA UNDER CURVE; C-REACTIVE PROTEIN; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FIBRINOGEN; HUMANS; INFECTION; LIVER DISEASES; MALE; MIDDLE AGED; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; WOUNDS AND INJURIES;

EID: 33845764810     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096786     Document Type: Article

References (18)

1. Bick RL: Disseminated intravascular coagulation: objective clinical and laboratory diagnosis, treatment, and assessment of therapeutic response. Semin Thromb Hemost 1996;22:69-88.
2. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001;86:1327-1330.
3. Bakhtiari K, Meijers JC, de Jonge E, Levi M: Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004;32:2416-2421.
4. Dempfle CE, Wurst M, Smolinski M, Lorenz S, Osika A, Olenik D, Fiedler F, Borggrefe M: Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score. Thromb Haemost 2004;91:812-818.
5. Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T: High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Am J Hematol 2003;72:1-7.
6. Sarris A, Cortes J, Kantarjian H, Pierce S, Smith T, Keating M, Koller C, Kornblau S, O'Brien S, Andreeff M: Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl. Leuk Lymphoma 1996;21:85-92.
7. Andreotti F, Burzotta F, Maseri A: Fibrinogen as a marker of inflammation: a clinical view. Blood Coagul Fibrinolysis 1999;10(suppl 1):S3-4.
8. Knobl PN: On the evaluation of the ISTH score for overt disseminated intravascular coagulation. Crit Care Med 2005;33:1185; author reply 1185-1186.
9. Levi M: Disseminated intravascular coagulation: what's new? Crit Care Clin 2005;21:449-467.
10. Dhainaut JF, Yan SB, Joyce DE, Pettila V, Basson B, Brandt JT, Sundin DP, Levi M: Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2004;2:1924-1933.
11. Levi M, Ten Cate H: Disseminated intravascular coagulation. N Engl J Med 1999;341:586-592.
12. Levi M, de Jonge E, van der Poll T, ten Cate H: Disseminated intravascular coagulation. Thromb Haemost 1999;82:695-705.
13. Povoa P, Almeida E, Moreira P, Fernandes A, Mealha R, Aragao A, Sabino H: C-reactive protein as an indicator of sepsis. Intensive Care Med 1998;24:1052-1056.
14. Dennis MW, Downey C, Brufatto N, Nesheim ME, Stevenson K, Toh CH: Prothrombinase enhancement through quantitative and qualitative changes affecting very low density lipoprotein in complex with C-reactive protein. Thromb Haemost 2004;91:522-530.
15. Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, Nelson DR: Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 2005;33:341-348.
16. Pettila V, Pentti J, Pettila M, Takkunen O, Jousela I: Predictive value of antithrombin III and serum C-reactive protein concentration in critically ill patients with suspected sepsis. Crit Care Med 2002;30:271-275.
17. Johnson A: Proteins; in Burtis C (ed): Tietz Textbook of Clinical Chemistry, ed 3. Philadelphia, Saunders, 1999, pp 477-540.
18. Thompson C, Blumenstock FA, Saba TM, Feustel PJ, Kaplan JE, Fortune JB, Hough L, Gray V: Plasma fibronectin synthesis in normal and injured humans as determined by stable isotope incorporation. J Clin Invest 1989;84:1226-1235.